These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23916330)

  • 41. Emerging and re-emerging infectious diseases.
    Peetermans WE; De Munter P
    Acta Clin Belg; 2007; 62(5):337-41. PubMed ID: 18229468
    [No Abstract]   [Full Text] [Related]  

  • 42. Management of multidrug-resistant organisms in health care settings, 2006.
    Siegel JD; Rhinehart E; Jackson M; Chiarello L;
    Am J Infect Control; 2007 Dec; 35(10 Suppl 2):S165-93. PubMed ID: 18068814
    [No Abstract]   [Full Text] [Related]  

  • 43. Emerging or re-emerging bacterial zoonotic diseases: bartonellosis, leptospirosis, Lyme borreliosis, plague.
    Higgins R
    Rev Sci Tech; 2004 Aug; 23(2):569-81. PubMed ID: 15702720
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MRSA infections decline, but new bacterial strains threaten. You can take action to protect yourself against drug-resistant bacteria.
    Duke Med Health News; 2010 Nov; 16(11):7. PubMed ID: 21186499
    [No Abstract]   [Full Text] [Related]  

  • 45. Should travelers be screened for multi-drug resistant (MDR) bacteria after visiting high risk areas such as India?
    Petersen E; Mohsin J
    Travel Med Infect Dis; 2016; 14(6):591-594. PubMed ID: 27913311
    [No Abstract]   [Full Text] [Related]  

  • 46. New and emerging infectious diseases.
    Elston DM
    J Am Acad Dermatol; 2005 Jun; 52(6):1062-8. PubMed ID: 15928626
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emerging and re-emerging infectious diseases: a continuous challenge for Europe.
    Quaglio G; Demotes-Mainard J; Loddenkemper R
    Eur Respir J; 2012 Dec; 40(6):1312-4. PubMed ID: 23204016
    [No Abstract]   [Full Text] [Related]  

  • 48. World Health Organization SAVE LIVES: Clean Your Hands global campaign-'Fight antibiotic resistance-it's in your hands'.
    Tartari E; Abbas M; Pires D; de Kraker MEA; Pittet D
    Clin Microbiol Infect; 2017 Sep; 23(9):596-598. PubMed ID: 28487167
    [No Abstract]   [Full Text] [Related]  

  • 49. An integrative review of infection prevention and control programs for multidrug-resistant organisms in acute care hospitals: a socio-ecological perspective.
    Backman C; Taylor G; Sales A; Marck PB
    Am J Infect Control; 2011 Jun; 39(5):368-378. PubMed ID: 21429622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preventing Transmission of Multidrug-Resistant Pathogens in the Intensive Care Unit.
    Strich JR; Palmore TN
    Infect Dis Clin North Am; 2017 Sep; 31(3):535-550. PubMed ID: 28687211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PulseNet China, a model for future laboratory-based bacterial infectious disease surveillance in China.
    Li W; Lu S; Cui Z; Cui J; Zhou H; Wang Y; Shao Z; Ye C; Kan B; Xu J
    Front Med; 2012 Dec; 6(4):366-75. PubMed ID: 23124882
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Costs and possible benefits of a two-tier infection control management strategy consisting of active screening for multidrug-resistant organisms and tailored control measures.
    Mutters NT; Günther F; Frank U; Mischnik A
    J Hosp Infect; 2016 Jun; 93(2):191-6. PubMed ID: 27112045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stopping HAIs at their source.
    Kenneley IL
    Nurse Pract; 2011 Sep; 36(9):47-51. PubMed ID: 21857217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effectiveness of bacteria-controlled nursing units in preventing cross-colonization with resistant bacteria in severely burned children.
    Weber JM; Sheridan RL; Schulz JT; Tompkins RG; Ryan CM
    Infect Control Hosp Epidemiol; 2002 Sep; 23(9):549-51. PubMed ID: 12269456
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ICAAC/ICC 2015.
    McConnell J
    Lancet Infect Dis; 2015 Nov; 15(11):1267. PubMed ID: 26531040
    [No Abstract]   [Full Text] [Related]  

  • 56. Knocking out nosocomial infections.
    Avalos-Bock S; Campbell V
    Nursing; 2004 Nov; 34(11):24-5. PubMed ID: 15686308
    [No Abstract]   [Full Text] [Related]  

  • 57. Emerging healthcare-associated problem pathogens in the United States.
    Jarvis WR; Sinkowitz-Cochran RL
    Postgrad Med; 2001 Feb; 109(2 Suppl):3-9. PubMed ID: 19667552
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Feasibility and efficacy of infection-control interventions to reduce the number of nosocomial infections and drug-resistant microorganisms in developing countries: what else do we need?
    Apisarnthanarak A; Fraser VJ
    Clin Infect Dis; 2009 Jan; 48(1):22-4. PubMed ID: 19067618
    [No Abstract]   [Full Text] [Related]  

  • 59. Healthcare epidemiology: active surveillance cultures and contact precautions for control of multidrug-resistant organisms: ethical considerations.
    Santos RP; Mayo TW; Siegel JD
    Clin Infect Dis; 2008 Jul; 47(1):110-6. PubMed ID: 18491966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emerging and Reemerging Infectious Diseases: Global Overview.
    Zumla A; Hui DSC
    Infect Dis Clin North Am; 2019 Dec; 33(4):xiii-xix. PubMed ID: 31668202
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.